Evaluating health interventions: Exploiting the potential

Health Policy

Volumn 63, Issue 2, 2003, Pages 215-226

  Maynard, Alan ^a,b   McDaid, David ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Economic evaluation; Economics based medicine; Health policy; Health technology assessment

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; QUALITY CONTROL; REVIEW;

EID: 0037304271     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(02)00068-4     Document Type: Article

References (42)

1. US Congressional Office of Technology Assessment. Identifying healthcare technologies that work: searching for the evidence. OTA-H-6808. Washington DC: US Government Printing Office, September 1994.
2. Williams A. Science or marketing at WHO?: rejoinder by Alan Williams. Health Economics. 10:(4):2001;283-286.
3. Cochrane A.L. Effectiveness and efficiency: random reflections on health services research. 1972;103 Nuffield Provincial Hospitals Trust, London.
4. Maynard A., Chalmers I. Non random reflections on health services research: on the 25th anniversary of Archie Cochrane's effectiveness and efficiency. 1997;303 BMJ Publishing, London.
5. Bunker J., Barnes J., Mosteller F. The costs, risks and benefits of surgery. 1977;Oxford University Press, Oxford.
6. Hoffmann C., Graf von der Schulenberg J.M. The influence of economic evaluation studies on decision making. A European survey. Health Policy. 52:2000;179-192.
7. Millbank Memorial Fund. Better information, better outcomes? The use of health technology assessment and clinical effectiveness data in health care purchasing decisions in the United Kingdom and the United States. New York: Millbank Memorial Fund, 2000.
8. Klein R. Setting priorities: what is holding us back - inadequate information or inadequate institutions? Coulter A., Ham C. The global challenge of health care rationing. 2000;Open University Press, Buckingham.
9. Bloor K., Maynard A. Rewarding health care team. British Medical Journal. 316:1998;569.
10. Bloor K., Maynard A. Reforming the contract for UK consultants. British Medical Journal. 322:2001;541-543.
11. Williams A. Science or marketing at WHO?: rejoinder by Alan Williams. Health Economics. 10:(4):2001;283-286.
12. Barer ML, Evans RE, Hertzman C, Johri M. Lies damned lies and health care Zombies: discredited ideas that will not die. Health Policy Institute Discussion Paper 10. Houston: University of Texas, March 1998.
13. Fries J. The impression of morbidity: near or far? Milbank Memorial Foundation Quarterly/Health and Society. 67:1989;208-222.
14. Manton K.G., Corder L., Stallard E. Chronic disability trends in elderly United States population 1982-94. Proceedings of the National Academy of Sciences of the United States of America. 94:(6):1982;2593-2598.
15. Jacobzone S, Cambois E, Robine JM. Is the health of older persons in OECD countries improving fast enough to compensate for population ageing? OECD Economic Studies No. 30, 2000/1 150-190. Paris: OECD, 2000.
16. Freemantle N., Bloor K. Lessons from international experience in controlling pharmaceutical expenditure I: influencing patients. British Medical Journal. 312:1996;1469-1471.
17. Bloor K., Freemantle N. Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors. British Medical Journal. 312:1996;1525-1527.
18. Bloor K., Maynard A., Freemantle N. Lessons from international experience in controlling pharmaceutical expenditure III: regulating industry. British Medical Journal. 313:1996;33-35.
19. Geddes J., Freemantle N., Harrison P., Bebbington P. A typical antipsychotics in the treatment of schizophrenia: systematic review and meta-regression analysis. British Medical Journal. 321:2000;1371-1376.
20. Lee P., Alexander K., Hammill B., Pasquali S., Peterson E. Representation of elderly persons and women in published randomised trials of acute coronary syndromes. Journal of the American Medical Association. 286:(6):2001;708-713.
21. The treatment of depression. Effective Health Care Bulletin Number 5 (March 1993). NHS Centre for Reviews and Dissemination: University of York, 1993.
22. Freemantle N., Behmare D., Joncherre K. Pricing and reimbursement of pharmaceuticals in the Baltic States. Lancet. 358:2001;260.
23. EUCOMED. HTA for medical devices - what has to be considered. Position paper. July 2001. Brussels: EUCOMED, 2001.
24. Sassi F., Archard L., Le Grand J. Equity and the economic evaluation of health care. Health Technology Assessment. 5:(3):2001;1-138.
25. Cookson R., McDaid D., Maynard A. Wrong SIGN, NICE mess. Is national guidance distorting resource allocation? British Medical Journal. 323:2001;743-745.
26. Landry R., Amara N. The impact of transaction costs on the institutional structuration of collaborative academic research. Research Policy. 27:(9):1998;901-914.
27. Knott J., Wildavsky A. If dissemination is the solution, what is the problem? Knowledge: Creation, Diffusion, Utilization. 1:(4):1980;537-578.
28. Lomas J. Using linkage and exchange to move research into policy at a Canadian Foundation. Health Affairs. 19:(3):2000;240-263.
29. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Audit and feedback: effects on professional practice and health care outcomes (Cochrane Review). In: The Cochrane Library, Issue 2 2001. Oxford: Update Software.
30. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Local opinion leaders: effects on professional practice and health care outcomes (Cochrane Review). In: The Cochrane Library, Issue 2 2001. Oxford: Update Software.
31. Zwarenstein M, Reeves S, Barr H, Hammick M, Koppel I, Atkins J. Inter-professional education: effects on professional practice and health care outcomes (Cochrane Review). In: The Cochrane Library, Issue 2 2001. Oxford: Update Software.
32. Bero L., Grilli R., Grimshaw J., Harvey E., Oxman A., Thomson M. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. British Medical Journal. 317:1998;465-468.
33. Organising Committee of Knowledge Transfer. Looking beyond health. Conference Proceedings. Toronto, October 2000. Available on-line at http://www.chsrf.ca/english/document-library/index.html.
34. Cookson R, Maynard A, McDaid D, Sassi F, Sheldon T, editors. Analysis of the scientific and technical evaluation of health care interventions in the European Union. Report to European Commission, July 2000. Available from http://www.lse.ac.uk/Depts/lsehsc/astec_report.htm.
35. Williams A. The cost-benefit approach. British Medical Bulletin. 30:(3):1974;252-256.
36. Drummond M.F., O'Brien B., Stoddart G., Torrance G.W. Methods for economic evaluation of health care programme. 2nd ed. 1997;356 Oxford University Press, Oxford.
37. Freemantle N., Maynard A. Something rotten in the state of clinical and economic evaluations? Health Economics. 3:1994;63-67.
38. Morgan S., Barer M., Evans R.E. Health economists meet the fourth tempter: drug dependency and scientific discourse. Health Economics. 9:(8):2000;659-668.
39. Reinhardt U.E. Making economic evaluations respectable. Social Science and Medicine. 45:(4):1997;555-562.
40. Maynard A. Economic evaluation techniques in health care: reinventing the wheel. Pharmacoeconomics. 11:1997;115-118. (February).
41. Baker L.C. Managed care and technology adoption in healthcare: evidence from magnetic resonance imaging. Journal of Health Economics. 20:2001;395-421.
42. Skrabanek P., McCormick J. Follies and fallacies in medicine. 2nd ed:1992;Tarragon Press, Glasgow, p. 170.